Prediction: Pfizer Will Beat the Market in Five Years
Pfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
Learn smart investing strategies for stocks, ETFs, bonds, and building long-term wealth.
17,689 articlesPfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
Viant DSP is navigating a fast-changing ad-tech landscape in 2026. This analysis breaks down Q1 dynamics, what the nu...
Tuesday brought a notable wobble for the Nasdaq-100, leading the market’s tech retreat. This article breaks down the ...
In the race to redefine urban air mobility, Joby Aviation and Archer Aviation stand out. This article highlights thre...
Oil markets are heating up as supply constraints tighten. Here are three solid stock ideas to consider before prices ...
Life360 delivered a strong quarter, but user growth hiccups and a lofty valuation rattled investors. This piece break...
Broadcom has surged after April began, but the big question remains: is the rally sustainable? This guide breaks down...
This article dives into exagen (XGN) 2026 earnings, unpacking Q1 results, business momentum, and the path to full-yea...
Disney reports a profitable quarter for its streaming arm, marking a profitability milestone that could spark upside ...
Tesla stock slides roughly 5% intraday as Elon Musk travels to China amid reports of robotaxi glitches and battery pr...
Palantir remains a topic of debate as dividend-focused peers outperform in choppy markets. Here’s how the latest move...
Greg Abel is quietly rebalancing Berkshire Hathaway’s equity book, moving away from U.S. financials and toward intern...